Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice
NCT01111240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4635
Last updated 2014-12-30
Summary
This study is a documentation of effectiveness and safety of Humira in patients with psoriatic arthritis.
Conditions
Sponsors & Collaborators
-
AbbVie (prior sponsor, Abbott)
lead INDUSTRY
Principal Investigators
-
Bianca Wittig, MD · Abbvie Deutschland GmbH & Co. KG, Medical Department
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants
NCT03419143 ·Status: COMPLETED
-
Clinical Trial Using Humira in Netherton Syndrome
NCT02113904 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
NCT00245960 ·Status: COMPLETED ·Phase: PHASE4
-
Etanercept (Enbrel) in Undifferentiated Spondyloarthritis
NCT01289730 ·Status: UNKNOWN ·Phase: PHASE2
-
Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
NCT00844142 ·Status: UNKNOWN ·Phase: PHASE2
-
Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis
NCT00938015 ·Status: COMPLETED
-
Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
NCT00696059 ·Status: COMPLETED ·Phase: PHASE4
-
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
NCT00432406 ·Status: COMPLETED ·Phase: PHASE4
-
Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice
NCT02202837 ·Status: COMPLETED
-
Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
NCT04428502 ·Status: COMPLETED
-
Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
NCT01412021 ·Status: COMPLETED
-
Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept
NCT01901185 ·Status: COMPLETED ·Phase: PHASE3
-
Defining Remission With Etanercept in AS in Real Life Clinical Practice
NCT02202850 ·Status: COMPLETED
-
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
NCT01387802 ·Status: COMPLETED
-
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
NCT04428424 ·Status: COMPLETED
-
Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site
NCT02771210 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria
NCT01877239 ·Status: COMPLETED
-
Enbrel® in Psoriatic Arthritis
NCT00111124 ·Status: COMPLETED ·Phase: PHASE4
-
Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital
NCT06601595 ·Status: NOT_YET_RECRUITING
-
Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
NCT04507763 ·Status: COMPLETED
-
Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?
NCT02164214 ·Status: COMPLETED ·Phase: PHASE3
-
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089 ·Status: COMPLETED
-
Etanercept (Enbrel) in Ankylosing Spondylitis
NCT01289743 ·Status: UNKNOWN ·Phase: PHASE2
-
Surveillance of Humira in Korean JIA Patients
NCT02141984 ·Status: COMPLETED
-
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
NCT01188655 ·Status: COMPLETED